Navigation Links
Verathon(R) Introduces BladderScan(R) BVM 9500 Bladder Volume Instrument To Help Urologists Diagnose Bladder Dysfunction
Date:4/28/2009

BOTHELL, Wash., April 28 /PRNewswire/ -- Verathon(R) is pleased to announce the new BladderScan(R) BVM 9500 bladder volume instrument. Designed with Urologists in mind, the BVM 9500 measures both UEBW (ultrasound-estimated bladder weight) and bladder volume quickly and noninvasively to help diagnose bladder dysfunction, including BPH (benign prostatic hypertrophy) and BOO (bladder outlet obstruction). This new addition to the BladderScan(R) BVI 9000 series made its official debut at the AUA 2009 conference in Chicago, IL on April 25. (Verathon Booth # 4623).

(Logo: http://www.newscom.com/cgi-bin/prnh/20061011/SFW044LOGO)

Bladder Outlet Obstruction (BOO) is reported to be one of the most common urologic problems among elderly male patients.(1) To date, definitive diagnosis of BOO has been achieved through invasive, time-consuming urodynamics testing.(2) Clinical studies indicate that the mass of the bladder wall may correlate with BOO.(3) The BladderScan(R) BVM 9500 provides Ultrasound-Estimated Bladder Weight (UEBW), a noninvasive measurement of bladder wall mass, in addition to urinary bladder volume (PVR, or post-void residual).

Like all BladderScan(R) bladder volume instruments, the BVM 9500 does not require a sonographer and is easy for staff to learn and use.

"The BladderScan(R) BVM 9500 provides urologists with a quick, accurate, easy to use instrument for measuring bladder volume and UEBW," said Gerald McMorrow, CEO, Founder and Chairman of the Board of Verathon, Inc. "This means Urologists can efficiently task staff to take the measurements, while allowing them to spend their time on diagnosis, treatment plans and communicating with their patients."

The portable BladderScan(R) BVM 9500 uses noninvasive ultrasound to measure bladder volume and UEBW to help diagnose urinary retention, evaluate common urological conditions and prevent unnecessary catheterization. The BVM 9500 also uses patent-pending NeuralHarmonics(TM) Technology to measure bladder volume. NeuralHarmonics(TM) Technology helps achieve previously unattainable differentiation of the bladder, urine and hypo-echogenic regions such as the uterus.

When the scan button is pressed on the BladderScan(R) BVM 9500, the instrument measures ultrasonic reflections on multiple planes inside the body and produces a three dimensional image. Based on this image, the BVM 9500 calculates and displays the bladder volume and UEBW on the color console. The instrument offers aiming assistance to the user, on both the probe and the console. To facilitate training, there is a brief 6 minute video tutorial on measuring bladder volume and UEBW on the device.

Unlike other ultrasound machines the portable BVM 9500 is quick and exam results can be provided in a matter of minutes during an office visit. The BVM 9500 instrument can save exam data to HIPAA-compliant ScanPoint(R) online imaging technology from Verathon(R). ScanPoint(R) technology provides the ability to view, save and print bladder volume or UEBW measurement reports as well as to quickly and easily calibrate BladderScan(R) instruments online.

For more information, please visit www.verathon.com.

About Verathon Inc.

Verathon designs and manufactures reliable, state-of-the-art medical devices and services that offer a meaningful improvement in patient care to the health care community. The company's noninvasive BladderScan(R) instrument is the standard of care for noninvasive bladder volume measurement. The brand is found in over 80 countries in Urology and Primary Care practices, as well as Acute and Extended Care facilities. With the January 2006 acquisition of Saturn Biomedical Systems in Vancouver, Canada, Verathon(R) entered Anesthesiology, Critical Care and Emergency markets with the GlideScope(R) Video Laryngoscope (GVL(R)) brand. Verathon(R) is headquartered in Bothell, Washington and has over 400 employees worldwide. For more information, please visit www.verathon.com.

Media Contact: Rick Goetter, Brand Director - BladderScan(R), Verathon Medical, 425.867.1348, Ext. 5608. Alternate Contacts: Jane Mueller, VP of Marketing, Verathon Medical, 425.867.1348, Ext. 5600 and

Nansea Carmichael, Executive Assistant - Marketing, 425.867.1348, Ext. 5607.

BladderScan, NeuralHarmonics, ScanPoint, GlideScope, GVL, and Verathon are trademarks of Verathon Inc.

2009 Verathon Inc.

References:

1. Kelly, Christopher E. "The Relationship Between Pressure Flow Studies and Ultrasound-Estimated Bladder Wall Mass." Rev Urol. 2005; 7 (suppl 6): S29-S34.

2. Nitti, Victor W. "Introduction: Measurement of Bladder Mass Using Ultrasonography: A New Tool for Measuring Bladder Outlet Obstruction." Rev Urol. 2005; 7 (suppl 6): S1-S2; Nitti, Victor W. "Pressure Flow Urodynamic Studies: The Gold Standard for Diagnosing Bladder Outlet Obstruction." Rev Urol. 2005; 7 (suppl 6): S14-S21.

3. Tubaro, A., C. Manieri, et. al. "The Effect of Bladder Outlet Obstruction Treatment on Ultrasound-Determined Bladder Wall Thickness." Rev Urol. 2005; 7 (suppl 6): S35-S42.


'/>"/>
SOURCE Verathon Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Verathon(R) Introduces BladderScan(R) BVI 9600 Bladder Volume Instrument with AortaScan(TM) Mode to Help Physicians Identify the Presence of Abdominal Aortic Aneurysms
2. GlideScope(R) Ranger Video Laryngoscope by Verathon(R) Awarded Airworthiness Certification by U.S. Army
3. Verathon(R) Offers Enhanced BladderScan(R) Instrument as Part of Continued Program to Eliminate Unnecessary Catheterizations, Decrease Urinary Tract Infections and Assist in Hospital Infection Control
4. Working Towards Counting Malaria Out Through Scale-Up of PermaNet(R) Bed Nets, Vestergaard Frandsen Produces 175 Millionth Net; Introduces New Net To Combat Insecticide Resistance
5. AdEx Media Introduces RezActiv(TM)
6. Chill Cooling Towels Introduces Instant Relief for Hot Flashes and Night Sweats
7. PercSys Introduces Accordion CoAx(TM) Stone Control Device for Facilitating Percutaneous Kidney Stone Treatments
8. Lumenis Introduces the HoLEP Simulator and the PolyScope Disposable Ureteroscope at American Urology Association 2009 Annual Meeting
9. Medstrat Introduces Depots!
10. SynCardia Introduces New 12-lb Freedom Discharge Driver Designed to Provide Quality 'Lifestyle' for Total Artificial Heart Patients
11. The ASDS Introduces the First At-Home Skin Cancer Exam Kit
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: